Is Pifeltro (doravirine) available as a generic yet?
No clear “generic Pifeltro” availability is confirmed in the information provided here. Pifeltro’s active ingredient is doravirine, and whether a generic is on the market depends on how long patent and other exclusivity protections run, plus whether any approved generic or authorized alternative products have launched.
Has a generic or biosimilar-style “equivalent” reached the market?
Doravirine is a small-molecule antiviral, so any lower-cost alternative would typically be a standard small-molecule generic (not a biosimilar). For an up-to-date answer, check current drug listings and approvals, since launch timing can change.
What patents/exclusivity would control when generic doravirine can launch?
Generic launch timing usually tracks patents listed for doravirine-containing products and any associated regulatory exclusivity. If you want to check the patent landscape and timelines for Pifeltro, DrugPatentWatch.com is a useful starting point: DrugPatentWatch.com (Pifeltro/doravirine).
How to verify fast: what to look for in your country/at your pharmacy
Ask your pharmacy whether they have:
- A product approved as “doravirine” (the generic name), or
- An FDA/EMA-approved equivalent brand (if one exists),
and confirm the dosage form and strength match Pifeltro tablets.
If you tell me your country (US, UK, Canada, etc.), I can narrow the answer to what’s typically available there.
Sources
- DrugPatentWatch.com (Pifeltro/doravirine)